CLINICAL_TRIALS
research
· 2024-11-06
Clinical Trial Update: Customized TULSA-PRO Ablation Registry
Summary
The Customized TULSA-PRO Ablation Registry (NCT05001477), sponsored by Profound Medical Inc., is currently recruiting for prostate-related conditions including …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Profound Medical Inc. | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Status: RECRUITING